As filed with the Securities and Exchange Commission on July 25, 2002
Registration No. 333-46394
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PHOTOGEN TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its charter)
| NEVADA (State or other jurisdiction of incorporation or organization) | 36-4010347 (I.R.S. Employer Identification Number) | |
140 Union Square Drive New Hope, PA 18938 (215) 862-6860 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) | ||
TAFFY J. WILLIAMS, PH.D. PRESIDENT AND CHIEF EXECUTIVE OFFICER PHOTOGEN TECHNOLOGIES, INC. 140 Union Square Drive New Hope, PA 18938 (215) 862-6860 (Name, address, including zip code, and telephone number, including area code, of agent for service) | ||
| COPIES TO: | ||
| THEODORE W. GRIPPO GRIPPO & ELDEN 227 WEST MONROE, STE. 3600 CHICAGO, ILLINOIS 60606 (312) 704-7700 |
Approximate date of commencement of proposed sale to the public: This post-effective amendment deregisters those shares of common stock that remain unsold hereunder as of the date hereof.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. o
On September 22, 2000, Photogen Technologies, Inc., a Nevada corporation, filed a registration statement on Form S-3 (No. 333-46394) using a "shelf" registration process to register $40,000,000 of common stock. On February 9, 2001, the Commission declared the Registration Statement effective. Since that time and from time to time, Photogen has filed prospectus supplements under the Registration Statement offering shares of common stock to Isosceles Fund Limited and Ballsbridge Finance Limited. In all, Photogen sold $1,125,000 worth of its common stock (695,486 shares total) under the Registration Statement, with $38,875,000 worth of common stock remaining unsold.
Photogen no longer desires to keep the Registration Statement effective. Accordingly, this Post-Effective Amendment No. 1 to the Registration Statement is being filed to deregister, as of the date hereof, all of the shares that remain unsold under the Registration Statement.
[The remainder of this page is intentionally left blank]
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Post-Effective Amendment on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Hope, Commonwealth of Pennsylvania on July 25, 2002.
| PHOTOGEN TECHNOLOGIES, INC. | |||
By: | /s/ TAFFY J. WILLIAMS, PH.D. Taffy J. Williams, Ph.D. Chief Executive Officer, President and Director | ||
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||||
|---|---|---|---|---|---|---|
By: | /s/ TAFFY J. WILLIAMS, PH.D. Taffy J. Williams, Ph.D. | President, Chief Executive Officer and Director, Chairman of the Board | July 25, 2002 | |||
By: | /s/ BROOKS BOVEROUX Brooks Boveroux | Senior Vice President—Finance and Chief Financial Officer and Treasurer (principal financial and accounting officer) | July 25, 2002 | |||
By: | /s/ ERIC A. WACHTER, PH.D.* Eric A. Wachter, Ph.D. | Director, Vice President and Secretary | July 25, 2002 | |||
By: | /s/ ROBERT J. WEINSTEIN, M.D.* Robert J. Weinstein, M.D. | Director | July 25, 2002 | |||
By: | /s/ LESTER H. MCKEEVER, JR.* Lester H. McKeever, Jr. | Director | July 25, 2002 | |||
By: | /s/ GENE GOLUB* Gene Golub | Director | July 25, 2002 | |||
By: | /s/ AIDAN KING* Aidan King | Director | July 25, 2002 | |||
*By: | /s/ TAFFY J. WILLIAMS, PH.D. Taffy J. Williams, Ph.D. Attorney-in-fact pursuant to powers of attorney included in Form S-3 Registration Statement (File No. 333-46394) as filed on September 22, 2000 |
